Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.332,40
0,00%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Protalix BioTherapeutics Inc (PLX) Protalix BioTherapeutics Inc (PLX) Notizie

Protalix BioTherapeutics Inc

PLX
1,12
-0,01 (-0,88%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:03:06
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/5/202423:05EDGAR2Form ARS - Annual Report to Security Holders
17/5/202423:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/5/202413:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202412:59EDGAR2Form 8-K - Current report
02/1/202412:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/12/202312:56EDGAR2Form 8-K - Current report
30/11/202310:00GLOBELevicept Appoints Eliot Forster as CEO
06/11/202313:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202313:22EDGAR2Form 8-K - Current report
31/10/202321:40APSUpcoming Earnings Release Paired With Price Target Raise..
20/10/202312:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202322:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/9/202312:58EDGAR2Form 8-K - Current report
06/9/202312:50PRNUSProtalix BioTherapeutics to Present at the H.C. Wainwright..
17/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202313:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202312:59EDGAR2Form 8-K - Current report
13/7/202322:41EDGAR2Form 8-K - Current report
07/7/202322:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/6/202313:24EDGAR2Form 8-K - Current report
28/6/202322:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
Apertura: 1,12 Min: 1,12 Max: 1,17
Chiusura: 1,13

La tua Cronologia

AMEX
PLX
Protalix BioTherapeutics
USOTC
GGNPF
PT Gudang Garam (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network